The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

The Motley Fool · Jake Lerch · 2026-11-07 14:15 UTC

PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

Read the full story at The Motley Fool · All coverage of this story